Channel Therapeutics Email Format
Biotechnology ResearchNew Jersey, United States11-50 Employees
Channel Therapeutics is a clinical-stage biotechnology company based in North Brunswick, New Jersey, focused on developing non-opioid, non-addictive therapeutics to alleviate pain and related conditions. Its lead program selectively targets the NaV1.7 sodium channel for the treatment of various chronic pains and acute eye pain. The firm operates as a small, research-oriented company within the biotechnology sector. In addition to its lead program, the Chromocell Therapeutics portfolio includes sublingual and intranasal disposable spray devices intended to treat mild to moderate pain, acute migraine, and chemotherapy- or surgery-related nausea and vomiting. The company aims to address patient needs by offering non-opioid pain management options for those suffering from pain and related conditions. Based in North Brunswick, New Jersey, the firm maintains a lean team advancing clinical development.